First Time Loading...

Pfizer Inc
NYSE:PFE

Watchlist Manager
Pfizer Inc Logo
Pfizer Inc
NYSE:PFE
Watchlist
Price: 27.81 USD 0.4% Market Closed
Updated: May 5, 2024

Balance Sheet

Balance Sheet Decomposition
Pfizer Inc

Current Assets 43.3B
Cash & Short-Term Investments 12.7B
Receivables 15.2B
Other Current Assets 15.5B
Non-Current Assets 183.2B
Long-Term Investments 15.4B
PP&E 18.9B
Intangibles 132.7B
Other Non-Current Assets 16.2B
Current Liabilities 47.8B
Accounts Payable 6.7B
Accrued Liabilities 2.8B
Short-Term Debt 8.1B
Other Current Liabilities 30.2B
Non-Current Liabilities 89.7B
Long-Term Debt 61.5B
Other Non-Current Liabilities 28.2B

Balance Sheet
Pfizer Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
3 343
3 641
2 595
1 342
1 139
1 121
1 784
1 944
416
2 853
Cash Equivalents
3 343
3 641
2 595
1 342
1 139
1 121
1 784
1 944
416
2 853
Short-Term Investments
32 779
19 649
15 255
18 650
17 694
8 525
10 437
29 125
22 316
9 837
Total Receivables
8 401
8 176
8 225
8 221
8 025
6 772
7 930
11 479
14 529
15 155
Accounts Receivables
8 401
8 176
8 225
8 221
8 025
6 772
7 930
11 479
10 952
11 177
Other Receivables
0
0
0
0
0
0
0
0
3 577
3 978
Inventory
5 663
7 513
6 783
7 578
7 508
7 068
8 046
9 059
8 981
10 190
Other Current Assets
5 409
4 825
6 091
5 350
15 560
9 317
6 870
8 086
5 017
5 299
Total Current Assets
55 595
43 804
38 949
41 141
49 926
32 803
35 067
59 693
51 259
43 334
PP&E Net
11 762
13 766
13 318
13 865
13 385
14 258
15 293
17 721
19 276
21 864
PP&E Gross
11 762
13 766
13 318
13 865
13 385
14 258
15 293
17 721
19 276
21 864
Accumulated Depreciation
13 226
13 502
14 807
16 172
16 591
14 990
14 812
15 074
15 174
16 045
Intangible Assets
35 166
40 356
52 648
48 741
35 211
33 936
28 471
25 146
43 370
64 900
Goodwill
42 069
48 242
54 449
55 952
53 411
48 202
49 577
49 208
51 375
67 783
Long-Term Investments
17 518
15 999
7 116
7 015
2 767
20 147
20 262
21 526
15 069
15 368
Other Long-Term Assets
5 456
5 214
5 135
5 083
4 722
18 248
5 559
8 182
16 856
13 253
Other Assets
42 069
48 242
54 449
55 952
53 411
48 202
49 577
49 208
51 375
67 783
Total Assets
167 566
N/A
167 381
0%
171 615
+3%
171 797
+0%
159 422
-7%
167 594
+5%
154 229
-8%
181 476
+18%
197 205
+9%
226 502
+15%
Liabilities
Accounts Payable
3 210
3 620
4 536
4 656
4 674
3 887
4 309
5 578
6 809
6 710
Accrued Liabilities
1 841
2 359
2 487
2 196
2 397
2 659
3 379
3 781
4 027
3 303
Short-Term Debt
2 130
6 440
6 463
6 407
4 055
14 733
701
605
395
8 096
Current Portion of Long-Term Debt
3 011
3 719
4 225
3 546
4 776
1 462
2 002
1 636
2 550
2 254
Other Current Liabilities
11 395
13 261
13 404
13 622
15 956
14 563
15 529
31 071
28 357
27 431
Total Current Liabilities
21 587
29 399
31 115
30 427
31 858
37 304
25 920
42 671
42 138
47 794
Long-Term Debt
31 541
28 740
31 398
33 538
32 909
35 955
37 133
36 195
32 884
61 538
Deferred Income Tax
23 317
26 877
30 753
3 900
3 700
5 652
4 063
349
1 023
640
Minority Interest
321
278
296
348
351
303
235
262
256
274
Other Liabilities
19 499
17 367
18 509
32 276
27 197
25 236
23 640
24 799
25 244
27 241
Total Liabilities
96 265
N/A
102 661
+7%
112 071
+9%
100 489
-10%
96 015
-4%
104 450
+9%
90 991
-13%
104 276
+15%
101 545
-3%
137 487
+35%
Equity
Common Stock
484
485
485
485
486
485
470
473
476
478
Retained Earnings
72 176
71 993
71 774
85 291
89 554
97 670
96 770
103 394
125 656
118 353
Additional Paid In Capital
78 977
81 016
82 685
84 278
86 253
87 428
88 674
90 591
91 802
92 631
Unrealized Security Profit/Loss
222
227
131
401
68
35
116
220
220
9
Treasury Stock
73 021
79 252
84 364
89 425
101 610
110 801
110 988
111 361
113 969
114 487
Other Equity
7 093
9 295
10 905
9 722
11 208
11 603
11 804
5 677
8 525
7 952
Total Equity
71 301
N/A
64 720
-9%
59 544
-8%
71 308
+20%
63 407
-11%
63 144
0%
63 238
+0%
77 200
+22%
95 660
+24%
89 014
-7%
Total Liabilities & Equity
167 566
N/A
167 381
0%
171 615
+3%
171 797
+0%
159 422
-7%
167 594
+5%
154 229
-8%
181 476
+18%
197 205
+9%
226 501
+15%
Shares Outstanding
Common Shares Outstanding
6 291
6 175
6 070
5 979
5 717
5 534
5 567
5 620
5 616
5 646
Preferred Shares Outstanding
0
0
0
0
0
0
0
0
0
0

See Also

Discover More